NR667- CEA FNP EXAM QUESTIONS
WITH CORRECT ANSWERS
A patient currently undergoing concurrent chemotherapy/radiation
| | | | | |
treatment for glottic squamous cell carcinoma is admitted to the rehab
| | | | | | | | | | |
unit you oversee for management of intractable nausea, vomiting, and
| | | | | | | | | |
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
| | | | | | | | | | | |
Which of the following conditions is this patient at risk for?
| | | | | | | | | |
A. Macrocytic anemia due to B12 deficiency
| | | | | |
B. Iron deficiency anemia due to chronic blood loss
| | | | | | | |
C. Microcytic anemia due to chronic kidney disease
| | | | | | |
D. Aplastic anemia due to bone marrow suppression
| | | | | | |
D
Your patient presents to the urgent care clinic with a swollen exudative
| | | | | | | | | | | |
pharynx, profound fatigue, and a very tender left upper quadrant
| | | | | | | | | |
abdomen. What is the most likely diagnosis?
| | | | | |
A. Strep pharyngitis
| |
B. Tonsillitis
|
C. Epstein Barr virus (EBV)
| | | |
D. Pancreatitis
|
C
,Which of the following best characterizes presbycusis in the older adult?
| | | | | | | | | |
A. Bilateral low-frequency sensorineural hearing loss
| | | | |
B. Bilateral high-frequency sensorineural hearing loss
| | | | |
C. Unilateral high-frequency sensorineural hearing loss
| | | | |
D. Unilateral low-frequency sensorineural hearing loss
| | | | |
B
A 35-year-old woman presents with allergic rhinitis, experiencing
| | | | | | | |
significant nasal congestion, sneezing, and itchy eyes. She has tried
| | | | | | | | | |
over-the-counter antihistamines with limited relief. What is the most | | | | | | | | |
appropriate next step in management? | | | |
A. Oral decongestants
| |
B. Nasal saline irrigation
| | |
C. Intranasal corticosteroids
| |
D. Referral to an allergist for immunotherapy
| | | | | |
C
A patient currently undergoing concurrent chemotherapy/radiation
| | | | | |
treatment for glottic squamous cell carcinoma is admitted to the rehab
| | | | | | | | | | |
unit you oversee for management of intractable nausea, vomiting, and
| | | | | | | | | |
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
| | | | | | | | | | | |
Which of the following conditions is this patient at risk for?
| | | | | | | | | |
A. Iron deficiency anemia due to chronic blood loss
| | | | | | | |
B. Microcytic anemia due to chronic kidney disease
| | | | | | |
C. Macrocytic anemia due to B12 deficiency
| | | | | |
D. Aplastic anemia due to bone marrow suppression
| | | | | | |
,D
A 78 y.o. M patient reports chronic infections, bruising, fatigue, SOB,
| | | | | | | | | | |
and fevers. He has a history of rectal adenocarcinoma and completed
| | | | | | | | | | |
concurrent chemotherapy/radiation earlier this year. His CBC shows Hgb
| | | | | | | |
7.5, PLT 88, WBC 1.2, ANC 0.8, and peripheral smear shows dysplasia.
| | | | | | | | | | | | |
What additional work-up would you anticipate for this patient?
| | | | | | | |
A. Colonoscopy and fecal occult blood test
| | | | | |
B. Bone marrow biopsy and flow cytometry
| | | | | |
C. No additional work-up is required, these are expected sequela of his
| | | | | | | | | | | |
oncologic treatment |
D. Repeat CBC/CMP/peripheral smear in eight weeks
| | | | | |
B
Progression to Acute Myelogenous Leukemia (AML) is a risk for
| | | | | | | | | |
untreated or poorly responsive: | | |
A. Pancytopenia
|
B. Aplastic anemia
| |
C. Macrocytic anemia
| |
D. Myelodysplastic syndrome
| |
D
Treatment for symptomatic aplastic anemia includes all the following
| | | | | | | | |
except:
A. Bone marrow transplant
| | |
B. PRBC/Platelet/WBC transfusions
| |
, C. Prophylactic antibiotics
| |
D. Removal of bone marrow stimulants
| | | | |
D
A patient diagnosed with iron deficiency anemia requires iron
| | | | | | | | |
supplementation. Which of the following treatments would likely be | | | | | | | | |
ineffective?
A. Ferrous sulfate 325 mg PO BID for a 43 y.o. F s/p gastric bypass 2
| | | | | | | | | | | | | | | |
years ago |
B. Iron sucrose 200 mg IV infusion weekly x 8 weeks in a 26 y.o. F at 34
| | | | | | | | | | | | | | | | | |
weeks of pregnancy | |
C. Ferrous sulfate 325 mg PO TID for a 25 y.o. F with menorrhagia
| | | | | | | | | | | | |
D. Ferrous sulfate 325 mg PO BID for a 63 y.o. M with ulcerative colitis
| | | | | | | | | | | | | |
A
Which of the following is not a common mechanism of neutrophil
| | | | | | | | | | |
expenditure and resultant neutropenia? | | |
A. Decreased neutrophil production in the bone marrow
| | | | | | |
B. Redistribution of neutrophils to the spleen or vascular endothelium
| | | | | | | | |
C. Loss of circulating neutrophils in acute blood loss
| | | | | | | |
D. Immune destruction
| |
C
Which of the following blood lead levels (BLL) would likely require
| | | | | | | | | | |
chelation therapy? |
A. < 80 mcg/dL
| | |
WITH CORRECT ANSWERS
A patient currently undergoing concurrent chemotherapy/radiation
| | | | | |
treatment for glottic squamous cell carcinoma is admitted to the rehab
| | | | | | | | | | |
unit you oversee for management of intractable nausea, vomiting, and
| | | | | | | | | |
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
| | | | | | | | | | | |
Which of the following conditions is this patient at risk for?
| | | | | | | | | |
A. Macrocytic anemia due to B12 deficiency
| | | | | |
B. Iron deficiency anemia due to chronic blood loss
| | | | | | | |
C. Microcytic anemia due to chronic kidney disease
| | | | | | |
D. Aplastic anemia due to bone marrow suppression
| | | | | | |
D
Your patient presents to the urgent care clinic with a swollen exudative
| | | | | | | | | | | |
pharynx, profound fatigue, and a very tender left upper quadrant
| | | | | | | | | |
abdomen. What is the most likely diagnosis?
| | | | | |
A. Strep pharyngitis
| |
B. Tonsillitis
|
C. Epstein Barr virus (EBV)
| | | |
D. Pancreatitis
|
C
,Which of the following best characterizes presbycusis in the older adult?
| | | | | | | | | |
A. Bilateral low-frequency sensorineural hearing loss
| | | | |
B. Bilateral high-frequency sensorineural hearing loss
| | | | |
C. Unilateral high-frequency sensorineural hearing loss
| | | | |
D. Unilateral low-frequency sensorineural hearing loss
| | | | |
B
A 35-year-old woman presents with allergic rhinitis, experiencing
| | | | | | | |
significant nasal congestion, sneezing, and itchy eyes. She has tried
| | | | | | | | | |
over-the-counter antihistamines with limited relief. What is the most | | | | | | | | |
appropriate next step in management? | | | |
A. Oral decongestants
| |
B. Nasal saline irrigation
| | |
C. Intranasal corticosteroids
| |
D. Referral to an allergist for immunotherapy
| | | | | |
C
A patient currently undergoing concurrent chemotherapy/radiation
| | | | | |
treatment for glottic squamous cell carcinoma is admitted to the rehab
| | | | | | | | | | |
unit you oversee for management of intractable nausea, vomiting, and
| | | | | | | | | |
dehydration. Admission CBC showed WBC 1.3, Hgb 7.5, PLT 45, ANC 0.8.
| | | | | | | | | | | |
Which of the following conditions is this patient at risk for?
| | | | | | | | | |
A. Iron deficiency anemia due to chronic blood loss
| | | | | | | |
B. Microcytic anemia due to chronic kidney disease
| | | | | | |
C. Macrocytic anemia due to B12 deficiency
| | | | | |
D. Aplastic anemia due to bone marrow suppression
| | | | | | |
,D
A 78 y.o. M patient reports chronic infections, bruising, fatigue, SOB,
| | | | | | | | | | |
and fevers. He has a history of rectal adenocarcinoma and completed
| | | | | | | | | | |
concurrent chemotherapy/radiation earlier this year. His CBC shows Hgb
| | | | | | | |
7.5, PLT 88, WBC 1.2, ANC 0.8, and peripheral smear shows dysplasia.
| | | | | | | | | | | | |
What additional work-up would you anticipate for this patient?
| | | | | | | |
A. Colonoscopy and fecal occult blood test
| | | | | |
B. Bone marrow biopsy and flow cytometry
| | | | | |
C. No additional work-up is required, these are expected sequela of his
| | | | | | | | | | | |
oncologic treatment |
D. Repeat CBC/CMP/peripheral smear in eight weeks
| | | | | |
B
Progression to Acute Myelogenous Leukemia (AML) is a risk for
| | | | | | | | | |
untreated or poorly responsive: | | |
A. Pancytopenia
|
B. Aplastic anemia
| |
C. Macrocytic anemia
| |
D. Myelodysplastic syndrome
| |
D
Treatment for symptomatic aplastic anemia includes all the following
| | | | | | | | |
except:
A. Bone marrow transplant
| | |
B. PRBC/Platelet/WBC transfusions
| |
, C. Prophylactic antibiotics
| |
D. Removal of bone marrow stimulants
| | | | |
D
A patient diagnosed with iron deficiency anemia requires iron
| | | | | | | | |
supplementation. Which of the following treatments would likely be | | | | | | | | |
ineffective?
A. Ferrous sulfate 325 mg PO BID for a 43 y.o. F s/p gastric bypass 2
| | | | | | | | | | | | | | | |
years ago |
B. Iron sucrose 200 mg IV infusion weekly x 8 weeks in a 26 y.o. F at 34
| | | | | | | | | | | | | | | | | |
weeks of pregnancy | |
C. Ferrous sulfate 325 mg PO TID for a 25 y.o. F with menorrhagia
| | | | | | | | | | | | |
D. Ferrous sulfate 325 mg PO BID for a 63 y.o. M with ulcerative colitis
| | | | | | | | | | | | | |
A
Which of the following is not a common mechanism of neutrophil
| | | | | | | | | | |
expenditure and resultant neutropenia? | | |
A. Decreased neutrophil production in the bone marrow
| | | | | | |
B. Redistribution of neutrophils to the spleen or vascular endothelium
| | | | | | | | |
C. Loss of circulating neutrophils in acute blood loss
| | | | | | | |
D. Immune destruction
| |
C
Which of the following blood lead levels (BLL) would likely require
| | | | | | | | | | |
chelation therapy? |
A. < 80 mcg/dL
| | |
